Scotiabank analyst Sung Ji Nam initiated coverage of Bionano Genomics with an Outperform rating and $4 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BNGO:
- Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results
- Bionano Genomics assumed with a Buy at BTIG
- Multi-Center Research Study Illustrates How OGM Can Potentially Result in More Patients Qualifying for Treatments in Leukemia
- Bionano Genomics announces publication of study evaluating OGM for AML samples
- Bionano Genomics Announces American Society of Hematology (ASH) Annual Meeting Presentations Featuring OGM Utility Across Blood Cancer Research Applications